The quinolones and renal infection

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 96-98

  Ronald, Allan ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CINOXACIN; CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE PYELONEPHRITIS; ANTIBIOTIC RESISTANCE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DRUG EFFICACY; DRUG EXCRETION; HUMAN; KIDNEY INFECTION; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; ORAL DRUG ADMINISTRATION; RASH; URINARY TRACT INFECTION; VOMITING;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; FLUOROQUINOLONES; HUMANS; KIDNEY DISEASES;

EID: 0032708274     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00019     Document Type: Conference Paper

References (12)

1. Preiksaitis JK, Thompson L, Harding GKM, et al. A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on faecal and periurethral carriage of Enterobacteriaceae. J Infect Dis 1981; 143: 603-8
2. Ronald AR, Turck M, Petersdorf RG. Nalidixic acid in the treatment of urinary tract infections. N Engl J Med 1966; 275: 1081-9
3. Sandberg T, Englund G, Lincoln K, et al. Randomized double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 1990; 9: 317-23
4. Bailey BR, Lynn KL, Robson RA, et al. Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. NZ Med J 1992; 105: 102-3
5. Stamm WE, Hooten TM. Management of urinary tract infection in adults. N Engl J Med 1993; 329: 1328-34
6. Thornsberry C, Marsilio MK, Jones ME, et al. Current activity of ciprofloxacin against gram-negative bacilli in the United States [abstract]. Sixth International Symposium on New Quinolones and Related Antibiotics; 1998 Nov 15-17; Denver, Colorado: 156
7. Hooten TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11: 551-81
8. Drusano GC, Johnson DE, Rosen M, et al. Pharmacodynamics of a fluoroquinolone antimicrobial in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother 1993; 37: 483-90
9. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988; 85: 793-8
10. Talan DA, Stamm WE, Reuning-Scherer J, et al. Treatment of acute uncomplicated pyelonephritis (AUP): a randomized double-blind trial comparing 7 versus 14 day therapy [abstract L-84]. Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1998 Sep 24-27; San Diego. Washington DC: American Society for Microbiology, 1998
11. Ronald AR, Harding GKM. Complicated urinary tract infections. Infect Dis Clin North Am 1997; 11: 583-97
12. Sheehan GJ, Harding GKM, Haase DA, et al. A double-blind randomized comparison of 24 weeks of norfloxacin to 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection. Antimicrob Agents Chemother 1988; 32: 1292-3